Skip to main content
. 2013 Jan 26;13:34. doi: 10.1186/1471-2407-13-34

Table 2.

Association of tumor GFRα1, GFRα3 and SDC3 mRNA expression with clinicopathologic parameters of patients with mammary carcinoma

 
GFRα1 expression (n (%))
GFRα3 expression (n (%))
SDC3 expression (n (%))
Parameter n mRNA P mRNA P mRNA P
Age (years)
≤ 35
16
14 (87.5)
0.005
11 (68.8)
0.043
8 (50.0)
0.399
35-55
92
45 (48.9)
 
40 (43.5)
 
33 (35.9)
 
> 55
51
21 (41.2)
 
17 (33.3)
 
16 (31.4)
 
Tumor size (cm)
≤ 2
13
6(46.2)
0.62
4 (30.8)
0.406
7 (53.8)
0.364
2 ~ 5
115
56 (48.7)
 
48 (417)
 
39 (33.9)
 
> 5
31
18 (58.1)
 
16 (51.6)
 
11 (35.5)
 
Histologic type
Ductal
150
78(52.0)
0.142
67(44.7)
0.127
54(36.0)
0.333
Lobular
6
2(33.3)
 
1(16.7)
 
1(16.7)
 
Mucinous
3
0(0)
 
0(0)
 
2(66.7)
 
Lymph node metastasis
0
55
20 (36.4)
0.013
19 (34.5)
0.235
23 (41.8)
0.481
1 ~ 3
55
28 (50.9)
 
24(43.6)
 
17 (30.9)
 
>3
49
32 (65.3)
 
25 (51.0)
 
17 (34.7)
 
Grade
I
13
8 (61.5)
0.436
6 (46.2)
0.678
7 (53.8)
0.124
II
102
53 (52.0)
 
41 (40.2)
 
31 (30.4)
 
III
44
19 (43.2)
 
21 (47.7)
 
19 (43.2)
 
Stage
I-II
85
32 (37.6)
0.001
32 (37.6)
0.162
31 (36.5)
0.861
III-IV
74
48 (64.9)
 
36(48.6)
 
26 (35.1)
 
ER status ^
-
94
49 (52.1)
0.582
37 (39.4)
0.297
31 (33.0)
0.364
+
65
31 (47.7)
 
31 (47.7)
 
26 (40.0)
 
PR status ^^
-
90
44 (48.9)
0.681
36 (40.0)
0.421
27 (30.0)
0.079
+
69
36 (52.2)
 
32 (46.4)
 
30 (43.5)
 
HER-2 *
-
121
53 (43.8)
0.003
47 (38.8)
0.074
44 (36.4)
0.809
+ 38 27 (71.1)   21 (55.3)   13 (34.2)  

^ ER positive required at least 10% staining nuclei.

^^ PR positive required at least 10% staining nuclei.

HER-2 positive were 3+ or 2+ and FISH confirmed.

Values in bold are significant (P < 0.05).